DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Cycloguanil

Cycloguanil

  • Plasmodium Falciparum Clinical Isolates: in Vitro Genotypic and Phenotypic Characterization Nonlawat Boonyalai1* , Brian A

    Plasmodium Falciparum Clinical Isolates: in Vitro Genotypic and Phenotypic Characterization Nonlawat Boonyalai1* , Brian A

  • Treatment Failure Due to the Potential Under-Dosing of Dihydroartemisinin-Piperaquine in a Patient with Plasmodium Falciparum Uncomplicated Malaria

    Treatment Failure Due to the Potential Under-Dosing of Dihydroartemisinin-Piperaquine in a Patient with Plasmodium Falciparum Uncomplicated Malaria

  • The Use of Long Acting Sulfonamides. Alone Or with Pyrimethamine, in Malaria (With Special Reference to Sulformetoxine)

    The Use of Long Acting Sulfonamides. Alone Or with Pyrimethamine, in Malaria (With Special Reference to Sulformetoxine)

  • Malarial Dihydrofolate Reductase As a Paradigm for Drug Development Against a Resistance-Compromised Target

    Malarial Dihydrofolate Reductase As a Paradigm for Drug Development Against a Resistance-Compromised Target

  • Evidence of Pyrimethamine and Cycloguanil Analogues As Dual Inhibitors of Trypanosoma Brucei Pteridine Reductase and Dihydrofolate Reductase

    Evidence of Pyrimethamine and Cycloguanil Analogues As Dual Inhibitors of Trypanosoma Brucei Pteridine Reductase and Dihydrofolate Reductase

  • Pyrimethamine and Proguanil Are the Two Most Widely Used DHFR Inhibitor Antimalarial Drugs. Cycloguanil Is the Active Metabolite of the Proguanil (1,2)

    Pyrimethamine and Proguanil Are the Two Most Widely Used DHFR Inhibitor Antimalarial Drugs. Cycloguanil Is the Active Metabolite of the Proguanil (1,2)

  • Current Antimalarial Therapies and Advances in the Development of Semi-Synthetic Artemisinin Derivatives

    Current Antimalarial Therapies and Advances in the Development of Semi-Synthetic Artemisinin Derivatives

  • Pyronaridine-Artesunate for Treating Uncomplicated Plasmodium Falciparum Malaria (Review)

    Pyronaridine-Artesunate for Treating Uncomplicated Plasmodium Falciparum Malaria (Review)

  • Investigating the Potential of Primary Sulfonamides As Antimalarial

    Investigating the Potential of Primary Sulfonamides As Antimalarial

  • Final1-Aritmo-Final-Report-V2-0Final.Pdf

    Final1-Aritmo-Final-Report-V2-0Final.Pdf

  • Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies

    Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies

  • Index Vol. 16-23

    Index Vol. 16-23

  • Plasmodium Falciparum Phenotypic and Genotypic Resistance Profile

    Plasmodium Falciparum Phenotypic and Genotypic Resistance Profile

  • Quinine) and to Prevent Malaria (Mefloquine, Cycloguanil) in Comoros Union and Madagascar

    Quinine) and to Prevent Malaria (Mefloquine, Cycloguanil) in Comoros Union and Madagascar

  • Development of Analytical Methods for the Determination of Antimalarials

    Development of Analytical Methods for the Determination of Antimalarials

  • Therapeutic Technologies: Selected Tropical Diseases Contents

    Therapeutic Technologies: Selected Tropical Diseases Contents

  • The Genetics of Resistance to Antifolate and Sulfa Drugs in Malaria Parasites

    The Genetics of Resistance to Antifolate and Sulfa Drugs in Malaria Parasites

  • ( 12 ) United States Patent

    ( 12 ) United States Patent

Top View
  • MALARONE® (Atovaquone and Proguanil Hydrochloride) Tablets MALARONE® (Atovaquone and Proguanil Hydrochloride) Pediatric Tablets
  • Australian Statistics on Medicines 2009
  • Quantitative Assessment of Plasmodium Falciparum PNAS PLUS Sexual Development Reveals Potent Transmission- Blocking Activity by Methylene Blue
  • Wo 2007/044693 A2
  • Molecular Surveillance and in Vitro Drug Sensitivity Study of Plasmodium Falciparum Isolates from the China–Myanmar Border
  • Cyclization-Blocked Proguanil As a Strategy to Improve the Antimalarial Activity of Atovaquone
  • In Silico Drug Discovery on Computational Grids for Finding Novel Drugs Against Neglected Diseases
  • Proguanil and Cycloguanil Are Organic Cation Transporter and Multidrug and Toxin Extrusion Substrates Maarten Van Der Velden1, Albert Bilos1, Jeroen J
  • Methods and Techniques for Assessing Exposure to Antimalarial Drugs in Clinical fi Eld Studies
  • Guidelines for the Treatment of Malaria
  • (12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al
  • Antimalarial Efficacy and Drug Interactions of the Novel Semi
  • Early Treatment Failure During Treatment of Plasmodium Falciparum
  • Synergism Between Antineoplastics and Antimalarials on Breast Cancer Cells
  • Minutes of 5Th TEG on Drug Efficacy and Response Meeting
  • Failure of Dihydroartemisinin-Piperaquine (DHA-PPQ) for the Treatment of P
  • [Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
  • A Population Pharmacokinetic Model of Piperaquine in Pregnant and Non


© 2024 Docslib.org    Feedback